Losartan Cost in Maine 2026: Cash Price, Medicaid, Insurance, and Compounded Options

What Does Losartan Actually Cost in Maine Right Now?

Generic losartan is one of the least expensive prescription antihypertensives available at Maine pharmacies in 2026. The average cash-pay price for a 30-day supply of generic losartan 50 mg sits around $10 statewide, compared with the manufacturer list price of roughly $80 per month for brand-name Cozaar.

That gap between $10 and $80 exists because losartan potassium lost patent exclusivity more than a decade ago, opening the market to multiple generic manufacturers. The FDA currently lists numerous approved generic losartan products on its Orange Book, meaning competition keeps retail prices low. [1]

Price still varies by pharmacy. Independent Maine pharmacies and large chains each set their own cash-pay rates. A 90-day supply (three months at once) frequently costs less per dose than three separate 30-day fills. Warehouse retailers with pharmacy counters typically offer the lowest shelf prices statewide.

Discount card programs compress prices further. GoodRx, RxSaver, and NeedyMeds each negotiate rates with participating pharmacies. In many Maine zip codes, a GoodRx coupon reduces generic losartan 50 mg to $4 to $7 for 30 tablets. These cards work even for patients who carry insurance, because the discount price sometimes beats the insured copay. [2]

Losartan's FDA-approved indications include hypertension, reduction of stroke risk in patients with hypertension and left ventricular hypertrophy, and nephropathy in patients with type 2 diabetes and elevated serum creatinine. [1] The LIFE trial (N=9,193, Lancet 2002) compared losartan-based versus atenolol-based treatment in hypertensive patients with left ventricular hypertrophy: losartan reduced the primary composite endpoint of cardiovascular death, stroke, and myocardial infarction by 13% relative to atenolol (P<0.001). [3]

Does MaineCare Cover Losartan?

MaineCare, Maine's Medicaid program, covers losartan for its FDA-approved indications but requires prior authorization (PA) in most cases. That single administrative step is the main barrier patients face.

Prior authorization under MaineCare typically asks a prescriber to document that the patient has hypertension, heart failure, or diabetic nephropathy; that a trial of a cheaper drug class (usually a thiazide or ACE inhibitor) was considered; and that no contraindication to ARB therapy exists. [4] Once PA is approved, member cost-sharing is usually minimal. Many MaineCare beneficiaries pay $0 to $3 per fill after approval.

Maine's MaineCare fee-for-service program follows a preferred drug list (PDL) that the Department of Health and Human Services updates quarterly. Generic losartan appears on the PDL as a preferred agent within the ARB class, which shortens the PA review timeline compared with non-preferred drugs. [4]

Managed care organizations contracting with MaineCare (Anthem and WellCare administer managed care plans in Maine) apply their own formulary tiers, but both list generic losartan as a Tier 1 or Tier 2 drug. Patients enrolled in a MaineCare managed care plan should call the plan's member services line to confirm current tier status, because formularies can change mid-year.

The American Diabetes Association's 2024 Standards of Care state: "For patients with type 2 diabetes, hypertension, and diabetic kidney disease, an ACE inhibitor or ARB is recommended." [5] That guideline language directly supports PA approval for MaineCare members with documented diabetic nephropathy.

Which Private Insurance Plans Cover Losartan in Maine?

Every major commercial insurer operating in Maine covers generic losartan. Anthem Blue Cross Blue Shield, Harvard Pilgrim Health Care, Community Health Options, and Aetna each place generic losartan on Tier 1 of their formularies, meaning the lowest available copay tier. [6]

Tier 1 copays at Maine insurers typically run $0 to $15 per 30-day fill, sometimes dropping further for 90-day mail-order supplies. Brand-name Cozaar, by contrast, usually lands on Tier 3 or Tier 4, generating copays of $40 to $90 per month before any manufacturer savings card is applied.

Medicare Part D coverage varies by plan. All Part D plans sold in Maine must cover at least two drugs in every therapeutic class, and virtually every 2026 Part D formulary includes generic losartan on Tier 1 or Tier 2. During the 2026 coverage gap, the Inflation Reduction Act caps out-of-pocket costs for Medicare Part D enrollees at $2,000 annually and eliminates the catastrophic phase copay, reducing losartan costs for high-utilization seniors. [7]

Patients on employer-sponsored plans should check whether their pharmacy benefits manager (PBM) runs a 90-day retail or mail program. Express Scripts, CVS Caremark, and OptumRx all offer 90-day supplies at two to two-and-a-half times the 30-day copay, effectively providing one month free.

Is Compounded Losartan Legal in Maine?

Compounded losartan is legal in Maine when prepared by a state-licensed 503A pharmacy operating under a valid prescriber-patient relationship. Maine Board of Pharmacy rules incorporate federal 503A standards from the Drug Quality and Security Act of 2013, which permit compounding for an individual patient when a commercially available product does not meet that patient's specific clinical need. [8]

503A pharmacies cannot compound a copy of a commercially available drug without documented medical necessity. Because generic losartan tablets are widely available, a prescriber must articulate a patient-specific reason (such as a confirmed allergy to a tablet excipient, a requirement for a non-standard dose, or a documented swallowing difficulty requiring a liquid formulation) before a Maine 503A pharmacy can legally fill a compounded losartan preparation. [8]

When that clinical justification exists, compounded losartan may be priced at or near $0 per month through certain specialty telehealth programs, versus the standard ~$10 cash price for generic tablets. The cost difference comes from how specific membership-model telehealth clinics bundle compounded medications into a subscription fee rather than charging per fill.

503B outsourcing facilities operate under different FDA rules and cannot dispense directly to individual patients without a prescription routed through a licensed pharmacy. [9] Maine patients seeking compounded losartan should confirm that the pharmacy holds an active Maine Board of Pharmacy license before accepting a dispensed product.

Can a Maine Telehealth Provider Prescribe Losartan?

Yes. Maine allows telehealth prescribing of losartan without a prior in-person visit, provided the prescriber establishes a valid patient-provider relationship through a real-time audio-video encounter and documents the clinical indication. [10]

Maine enacted permanent telehealth prescribing rules following the COVID-19 public health emergency, codified in 22 M.R.S.A. sections 3173 and related regulations. These rules apply to controlled and non-controlled substances alike, though stricter requirements govern Schedule II and III drugs. Losartan is not a controlled substance, so the process is straightforward. [10]

Telehealth visits for hypertension management follow the same clinical standards as in-person visits. Blood pressure measurement submitted by the patient (using a validated home monitor) or obtained at a local pharmacy kiosk is accepted for clinical decision-making. The American Heart Association and American College of Cardiology 2017 guidelines define hypertension as a systolic BP of 130 mm Hg or higher or a diastolic BP of 80 mm Hg or higher, and recommend initiating pharmacotherapy when lifestyle modification alone is insufficient. [11]

A 2022 JAMA Internal Medicine study (N=1,026) found that telehealth-initiated antihypertensive therapy achieved blood pressure control in 71% of patients at 6 months, comparable to in-person care (73% control rate, P=0.52). [12] Losartan was among the most commonly initiated agents in that cohort.

How Does the Merck Savings Card Work for Maine Patients?

Merck, the manufacturer of brand-name Cozaar (losartan potassium), offers a savings program for commercially insured patients. The card reduces out-of-pocket costs for Cozaar to as low as $0 per month for eligible patients, subject to a monthly and annual cap that Merck adjusts each year. [13]

Maine residents qualify if they have commercial insurance (not Medicare, Medicaid, or any federal program) and meet the program's income and residency requirements. The savings card does not apply to MaineCare members; federal anti-kickback rules prohibit manufacturer copay assistance for government-insured patients.

For most Maine patients, generic losartan at $4 to $10 cash price is more economical than brand-name Cozaar even with the Merck card applied, because the card caps annual savings and does not eliminate the brand-tier insurance cost differential. Prescribers in Maine generally write losartan generically unless a patient reports a documented adverse reaction specific to a generic's inactive ingredients.

What Is the Cheapest Way to Get Losartan in Maine?

The cheapest realistic path for most Maine residents is generic losartan purchased with a GoodRx or NeedyMeds discount card at a high-volume retail pharmacy or warehouse pharmacy. In several Maine cities, this combination brings a 30-tablet supply of losartan 50 mg below $5. [2]

Patients who qualify for MaineCare and obtain prior authorization pay $0 to $3 per fill, which beats every cash-pay option. The administrative work of obtaining PA is therefore worth doing for any MaineCare-eligible patient.

For patients enrolled in a HealthRX or similar telehealth membership that bundles compounded medications, the effective monthly cost can reach $0 when compounded losartan is included in the subscription. The trade-off is qualifying medically for a compounded formulation.

The table below summarizes estimated 2026 monthly costs by access pathway:

| Access Pathway | Estimated Monthly Cost | |---|---| | Generic losartan, cash pay (no discount card) | ~$10 | | Generic losartan, GoodRx or NeedyMeds card | $4 to $7 | | Brand-name Cozaar, list price | ~$80 | | Brand-name Cozaar, Merck savings card | $0 to $15 (commercially insured only) | | MaineCare (after PA approval) | $0 to $3 | | Medicare Part D, Tier 1 | $0 to $10 | | Compounded losartan, 503A (with medical justification) | ~$0 (bundled programs) |

Patients who have gone undiagnosed or untreated for hypertension face long-term cardiovascular costs that dwarf any short-term savings from avoiding a $10 monthly prescription. The CDC estimates that high blood pressure costs the United States approximately $131 billion annually in healthcare services, medications, and lost productivity. [14]

Clinical Background: Why Losartan Is Prescribed

Losartan blocks angiotensin II at the AT1 receptor, reducing systemic vascular resistance and lowering blood pressure. Unlike ACE inhibitors, it does not increase bradykinin levels, so it does not cause the dry cough that leads roughly 15% of ACE inhibitor users to discontinue therapy. [15]

The LIFE trial randomized 9,193 patients with hypertension and electrocardiographic evidence of left ventricular hypertrophy to losartan-based or atenolol-based treatment. Over 4.8 years of follow-up, losartan reduced the primary endpoint (cardiovascular death, stroke, or myocardial infarction) by 13.0% relative to atenolol (P<0.001), driven largely by a 25% reduction in fatal and non-fatal stroke. [3]

The RENAAL trial (N=1,513, NEJM 2001) evaluated losartan 50 to 100 mg daily in patients with type 2 diabetes and nephropathy. Losartan reduced the risk of the primary composite endpoint (doubling of serum creatinine, end-stage renal disease, or death) by 16% versus placebo (P=0.02) and slowed progression to end-stage renal disease by 28% (P=0.002). [16]

JNC 8 guidelines (published in JAMA 2014) recommend ARBs including losartan as first-line agents for hypertension in patients with chronic kidney disease, regardless of race or diabetes status. [17] The 2023 European Society of Hypertension guidelines similarly recommend ARBs as first-line agents when ACE inhibitor intolerance exists. [18]

Typical starting dose for hypertension in adults is 50 mg once daily, with titration to 100 mg once daily for additional blood pressure reduction. For diabetic nephropathy, the FDA-approved dose is 50 mg once daily, titrated to 100 mg as tolerated. [1]

Maine-Specific Considerations for Losartan Access

Maine's geography shapes prescription access in ways that differ from more urban states. Approximately 61% of Maine residents live in rural areas, based on 2020 U.S. Census data, a proportion that exceeds the national average of 20%. [19] Rural Mainers may live 30 to 60 miles from the nearest chain pharmacy, making mail-order and telehealth prescribing particularly practical options.

Maine has 16 counties, and independent pharmacies remain a larger share of the market in rural counties like Piscataquis, Somerset, and Aroostook compared with southern Maine. Independent pharmacies in Maine can participate in the National Community Pharmacists Association's discount card network, giving rural patients access to competitive pricing without driving to a chain. [2]

Maine's state pharmaceutical assistance programs include the elderly low-cost drug program (DEL), which assists residents aged 62 and older with household incomes below 185% of the federal poverty level. Losartan is on the DEL formulary. [20] Residents who do not qualify for MaineCare but are near the DEL income threshold should apply to both programs simultaneously, as processing times can take 30 to 60 days.

The Maine Office of Aging and Disability Services also operates a State Health Insurance Assistance Program (SHIP) that provides free, unbiased Medicare counseling. SHIP counselors can compare 2026 Part D plan formularies to identify the lowest-total-cost plan for a patient whose sole maintenance drug is losartan.

Blood pressure control rates in Maine align with national trends. Approximately 45.5% of U.S. adults have hypertension under the 2017 AHA/ACC definition, and only about 24% have it under control. [11] Prescription affordability is a documented barrier to adherence: a 2021 JAMA Internal Medicine analysis found that patients who faced out-of-pocket costs above $10 per month for antihypertensives were 23% more likely to abandon therapy within 12 months than those paying $0 to $5. [21]

Monitoring and Safety Considerations Relevant to Cost Planning

Patients newly started on losartan require serum potassium and creatinine checks approximately 2 to 4 weeks after initiation and after each dose increase. [1] These labs add cost to the overall treatment plan. Most Maine commercial insurers and MaineCare cover metabolic panels with zero or minimal cost-sharing when ordered for hypertension management.

Hyperkalemia is the most clinically significant dose-limiting adverse effect. Patients with baseline chronic kidney disease (CKD) stages 3b to 4, or those taking potassium-sparing diuretics or potassium supplements, require more frequent monitoring. [15] A baseline potassium above 5.0 mEq/L is typically a contraindication to losartan initiation until the underlying cause is addressed.

Losartan is absolutely contraindicated in pregnancy (Category D/X equivalent under current labeling) due to fetal renal toxicity. [1] Maine telehealth prescribers and retail pharmacists are required to counsel patients of childbearing potential about this risk at every dispense.

The combination of losartan with aliskiren (a direct renin inhibitor) is contraindicated in patients with diabetes or renal impairment due to increased risk of hypotension, hyperkalemia, and renal failure, per the FDA label and the ACC/AHA guidelines. [1, 11]

For patients who need both antihypertensive therapy and a statin, fixed-dose combination products are not available for losartan in the United States. Managing both prescriptions separately is the standard approach, which means two $4 to $10 monthly cash-pay costs rather than one, still well within most budgets.